Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHelios Towers Regulatory News (HTWS)

Share Price Information for Helios Towers (HTWS)

Share Price is delayed by 15 minutes
Get Live Data
219.60    -0.40 (-0.18%)
Bid:
218.80
Ask:
219.00
Spread: 0.20 (0.091%)
Market Cap: £2.24b
HTWS Live PriceLast checked at - London Stock Exchange

Intraday Helios Towers Share Chart

Equity Placing in Helios Towers PLC

18 Jun 2020 07:00

RNS Number : 3479Q
Citigroup Global Markets Limited
18 June 2020
 

 

NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA.

THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED TO CONSTITUTE INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) NO.596/2014. UPON THE PUBLICATION OF THIS ANNOUNCEMENT, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

Press Release

Successful completion of the sale of ordinary shares in Helios Towers Plc ("Helios Towers" or the "Company")

18 June 2020

Network i2i Limited, wholly owned subsidiary of Bharti Airtel Limited, (the "Seller") hereby announces the sale of 23.1 million existing ordinary shares in Helios Towers ("Placing Shares"), (the "Placing"). The Placing Shares represented approximately 2.3% of Helios Towers' issued ordinary share capital. Following the sale, the Seller will no longer hold any of the Company's issued ordinary share capital.

Gross sale proceeds of the offering amounted to £36.9m, equal to £1.60 for each ordinary share. The sale will be settled on 22 June 2020.

Citigroup Global Markets Limited ("Citi") acted as Joint Bookrunner in connection with the offering. BofA Securities acted as Joint Bookrunner (passive).

Helios Towers will not receive any proceeds from the Placing.Enquiries:

Citigroup Global Markets Limited (Joint Bookrunner)

Ken Robins

Gulfraz Qayyum

Chuba Ezenwa

Mihir Unadkhat

 

+44 (0) 20 7500 5000

 

BofA Securities (Joint Bookrunner (passive))

Amit Shah

Raj Batra

Andrew Briscoe

 

 

+44 (0) 20 7628 1000

 

 

IMPORTANT NOTICE

This announcement is not for publication, distribution or release, directly or indirectly, in or into the United States of America (including its territories and possessions), Australia, Canada, Japan or the Republic of South Africa or any other jurisdiction where such an announcement would be unlawful. The distribution of this announcement may be restricted by law in certain jurisdictions and persons into whose possession this document or other information referred to herein comes should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.

This announcement is not an offer of securities or investments for sale nor a solicitation of an offer to buy securities or investments in any jurisdiction where such offer or solicitation would be unlawful. No action has been taken that would permit an offering of the securities or possession or distribution of this announcement in any jurisdiction where action for that purpose is required. Persons into whose possession this announcement comes are required to inform themselves about and to observe any such restrictions.

The Placing Shares may not be offered to the public in any jurisdiction in circumstances which would require the preparation or registration of any prospectus or offering document relating to the Placing Shares in such jurisdiction. No action has been taken by the Seller or any of its affiliates, that would permit an offering of the Placing Shares or possession or distribution of this announcement or any other offering or publicity material relating to such securities in any jurisdiction where action for that purpose is required.

The securities referred to herein have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), and, subject to certain exemptions, may not be offered or sold in the United States (as defined in Regulation S under the Securities Act). Neither this document nor the information contained herein constitutes or forms part of an offer to sell or the solicitation of an offer to buy securities in the United States. There will be no public offer of any securities in the United States or in any other jurisdiction.

In the United Kingdom and member states of the European Economic Area, this announcement and any offer if made subsequently is directed exclusively at persons who are "qualified investors" within the meaning of the Prospectus Regulation (Regulation (EU) 2017/1129) ("Qualified Investors"). In the United Kingdom this announcement is directed exclusively at Qualified Investors (i) who have professional experience in matters relating to investments falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the "Order") or (ii) who fall within Article 49(2)(A) to (D) of the Order, or (iii) to whom it may otherwise lawfully be communicated (all such persons together being referred to as "Relevant Persons"). This document is directed only at Relevant Persons and must not be acted on or relied on by persons who are not Relevant Persons. Any investment or investment activity to which this document relates is available only to Relevant Persons and will be engaged in only with Relevant Persons. This announcement is not an offer of securities or investments for sale nor a solicitation of an offer to buy securities or investments in any jurisdiction where such offer or solicitation would be unlawful. No action has been taken that would permit an offering of the securities or possession or distribution of this announcement in any jurisdiction where action for that purpose is required. Persons into whose possession this announcement comes are required to inform themselves about and to observe any such restrictions.

In connection with any offering of the Placing Shares, the Joint Bookrunners and any of their respective affiliates acting as an investor for their own account may take up as a proprietary position any Placing Shares and in that capacity may retain, purchase or sell for their own account such Placing Shares. In addition they may enter into financing arrangements and swaps with investors in connection with which they may from time to time acquire, hold or dispose of Placing Shares. They do not intend to disclose the extent of any such investment or transactions otherwise than in accordance with any legal or regulatory obligation to do so.

Citi, which is authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and the Prudential Regulation Authority and Merrill Lynch International, which is authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and the Prudential Regulation Authority, are acting on behalf of the Seller and no one else in connection with any offering of the Placing Shares and will not be responsible to any other person for providing the protections afforded to any of its clients or for providing advice in relation to any offering of the Placing Shares. The Joint Bookrunners will not regard any other person as its client in relation to the offering of the Placing Shares.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ROIEVLBFBQLEBBX
Date   Source Headline
6th Oct 20259:15 amRNSHolding(s) in Company
3rd Oct 20257:04 amRNSHolding(s) in Company
1st Oct 20257:00 amRNSResults of convertible bond tender
30th Sep 20255:27 pmRNSLaunch of convertible bond tender
19th Sep 20252:56 pmRNSDirector/PDMR Shareholding
18th Sep 20259:34 amRNSHolding(s) in Company
15th Sep 20252:36 pmRNSHelios Towers_TR1_Notification FCA Submitted
11th Sep 20257:00 amRNSAppointment of Corporate Broker
21st Aug 202511:17 amRNSDirector Declaration
31st Jul 20257:00 amRNSH1 2025 Results
3rd Jul 20257:00 amRNSNotice of H1 2025 Results Date & Conference Call
1st Jul 20259:41 amRNSHolding(s) in Company
1st Jul 20257:00 amRNSBlock Listing Application
23rd Jun 20251:27 pmRNSHolding(s) in Company
18th Jun 20251:16 pmRNSDirector/PDMR Shareholding
16th May 20257:00 amRNSChange of Director Responsibilities
15th May 20253:32 pmRNS2025 Annual General Meeting Results
9th May 20254:35 pmRNSHolding(s) in Company
8th May 20257:00 amRNSQ1 2025 Results
6th May 20258:30 amRNSBlock Listing Six Monthly Return
9th Apr 20257:00 amRNSNotice of Q1 2025 Results Date & Conference Call
8th Apr 20258:36 amRNSHolding(s) in Company
8th Apr 20258:32 amRNSHolding(s) in Company
7th Apr 202510:18 amRNSAnnual Report and Notice of AGM
31st Mar 20259:45 amRNSTotal Voting Rights
28th Mar 20256:19 pmRNSHolding(s) in Company
17th Mar 20251:21 pmRNSDirector/PDMR Shareholding
14th Mar 20254:36 pmRNSNotification of Major Holdings
4th Feb 20259:18 amRNSHolding(s) in Company
21st Jan 20257:00 amRNSNotice of FY 2024 Results Date & Conference Call
8th Jan 20257:00 amRNSHolding(s) in Company
6th Jan 20252:33 pmRNSChange to a Director’s Role and Responsibilities
19th Dec 202410:53 amRNSDirector/PDMR Shareholding
9th Dec 202411:02 amRNSDirector/PDMR Shareholding
26th Nov 20249:09 amRNSHolding(s) in Company
22nd Nov 20247:00 amRNSHolding(s) in Company
20th Nov 202410:07 amRNSDirector/PDMR Shareholding
20th Nov 20247:00 amRNSRESULTS OF SECONDARY PLACING OF HELIOS TOWERS PLC
19th Nov 20244:47 pmRNSPROPOSED SECONDARY PLACING IN HELIOS TOWERS PLC
19th Nov 20243:40 pmRNSHolding(s) in Company
7th Nov 20247:00 amRNSQ3 2024 Results
4th Nov 20247:00 amRNSBlock Listing Six Monthly Return
8th Oct 20247:00 amRNSNotice of Q3 2024 Results Date & Conference Call
30th Sep 20241:04 pmRNSHolding(s) in Company
16th Sep 20247:00 amRNSAppointment of Non-Executive Director
8th Aug 20247:00 amRNSHalf-year Report
3rd Jul 20247:00 amRNSNotice of H1 2024 Results Date & Conference Call
20th Jun 20246:02 pmRNSHolding(s) in Company
20th Jun 20243:24 pmRNSDirector/PDMR Shareholding
19th Jun 20245:44 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.